Anticancer Drugs II Flashcards

1
Q

what are the alkylating agents

A

MANNT

Methylhydrazines
Alkyl Sulfonates
Nitrogen Mustards
Nitrosoureas
Triazenes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

mechanism of action of alkylating agents

A

-transfer of alkyl groups to DNA sites such as N7 position of guanine (there are other sites)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what is an additional mechanism that occurs with alkylation agents Nitrosoureas

A

carbamoylation of lysine residues of proteins through formation of isocyanates

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what are the nitrogen mustards

A

CIMM

Cyclophosphamide
Ifosfamide
Mechlorethamine
Melphalan

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what is cyclophosphamide converted to and by what enzyme

A

converted to 4 hydroxycyclophosphamide by CYP2B6, which has the most 4 hydroxylase activity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

adverse effect of cyclophosphamide

A

Hemorrhage Cystitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what is responsible for the hemorrhage cystitis seen with cyclophosphamide and how can it be prevented

A

Acrolein, metabolite of cyclophosphamide, is responsible

-prevented by parenteral administration of Mesna, sulfhydryl compound, that reacts with acrolein in the bladder

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what is Ifosfamide

A

it is an analogue of cyclophoshamide hence needs Mesna to prevent hemorrhagic cystitis as well

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what is Mechlorethamine

A

an alkylating agent that is also a powerful vesicant (blistering agent)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what is Melphalan used for

A

Multiple Myeloma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what are the Nitrosoureas

A

Carmustine (IV)

Lomustine (orally)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

types of activity do nitrosoureas have (name them)

A

carmustine and lomustine

they have both alkylating activity and carbamoylating activity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

clinical application of nitrosoureas (name them)

A

carmustine and lomustine

they are highly lipid soluble and can cross the BBB so used for brain tumors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

what is the alkyl sulfonates

A

Busulfan

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what is the methylhydrazines

A

Procarbazine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

adverse effect of methylhydrazines

A
  • MOA inhibitor and can be potentiated if given with sympathomimetic agents and tyramine containing foods
  • carcinogenic: increased risk of secondary cancers as compared to other alkylating agent
17
Q

name the triazenes

A

dacarbazine

18
Q

what are the two potent vesicant

A

Triazene: Dacarbazine

Nitrogen mustard: Mechlorethamine

19
Q

what are the platinum complexes

A

Cisplatin

Carboplatin

20
Q

mechanism of the platinum complexes (name them)

A

Cisplatin and Carboplatin

inhibits DNA synthesis and binds DNA through formation of cross links

21
Q

Cisplatin is used in combination with what drugs and to treat what

A

combination with Vinblastin and Bleomycin to treat nonseminomatous testicular cancer

22
Q

adverse effects of platinum complexes (name them)

A

Cisplatin and Carboplatin

Ototoxicity
Nephrotoxicity
Peripheral Neuropathy

23
Q

what can be used to prevent the Cisplatin induced nephrotoxicity

A

hydration and diuresis

Amifostine - thiophosphate cytoprotective agent

24
Q

what the anticancer hormonal agents

A

HORMONAL AGE

Androgen Inhibitors
Glucocorticoids
Estrogen Inhibitors

25
Q

what glucocorticoids is used in treatment of cancer and its mechanism

A

Prednisone: induces lymphocyte apoptosis

26
Q

name the estrogen inhibitors according to class

A
  • Selective Estrogen Receptor Modulators (SERMs): Tamoxifen and Raloxifene
  • Selective Estrogen Receptor Downregulators (SERDs): Fulvestrant
  • Aromatase Inhibitors: Anastrozole, Letrozole, Exemestane
27
Q

what are the selective estrogen receptor modulators (SERMs)

A

Tamoxifen

Raloxifene

28
Q

mechanism of tamoxifen and clinical application

A

anti estrogen effect at the breast but estrogen receptor agonist in the endometrium and bone

used to treat breast cancer

29
Q

adverse effect of tamoxifen

A

Endometrial Hyperplasia
Hot flashes
Thromboembolic Events

30
Q

mechanism of Raloxifene

A

estrogen antagonist in the breast and endometrium

estrogen agonist in the bone (prevent osteoporosis in post menopausal women)

31
Q

what is the selective estrogen receptor downregulators (SERDs)

A

Fulvestrant

32
Q

mechanism of selective estrogen receptor downregulator (name it) and when used

A

fulvestrant

pure estrogen antagonist with no agonist activity
-used in tamoxifen resistant breast cancer

33
Q

what are the aromatase inhibitors

A

Anastrozole
Letrozole
Exemestane

34
Q

mechanism of the aromatase inhibitors

A

Anastrozole and Letrozole are nonsteroidal competitive inhibitors of aromatase

Exemestane is a steroidal non competitive inhibitor of aromatase

35
Q

what are the androgen inhibitors

A

Androgen inhibitor: Goserelin and Leuprolide

Androgen Receptor Inhibitor: Flutamide

36
Q

name the androgen receptor inhibitor and its mechanism

A

Flutamide: non steroid competitive antagonist of the androgen receptor used for prostatic carcinoma

37
Q

adverse of flutamide

A

mild gynecomastia since it is blocking androgen receptor

38
Q

mechanism of Goserelin and Leuprolide

A

androgen inhibitors

  • gonadotropin releasing (GnRH) analogues that stimulate the release of gonadal hormones
  • Initially: 7-10 days, they increase gonadal hormone production which can be inhibited by flutamide
  • delayed: with continued GnRH analogues, there becomes an inhibitory action to reduce gonadal hormone release